Home>Topics>Stocks>Alexion Pharmaceuticals

Alexion Pharmaceuticals ALXN

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. ETF Reports
  6. Headlines
    1. A Sharp Pullback In Celldex Could Be A Window Of Opportunity

      Headlines

      Tue, 8 Apr 2014

      By Stephen Simpson, CFA : To buy when others seemingly can't sell fast enough takes a lot of guts (and other less family-friendly attributes), but it can be one of the best ways to exploit Wall Street shortsightedness. Small-cap oncology immunotherapy biotech Celldex ( CLDX ) has gotten swept up in

    2. The Biotech Sell Off Is Largely Indiscriminate And The Best Stocks Are Not Over-Valued

      Headlines

      Mon, 31 Mar 2014

      for Top 10 FBIOX Holdings Gilead ( GILD ) -18% Amgen ( AMGN ) - 2% Biogen ( BIIB ) -14% Celgene ( CELG ) -14% Alexion ( ALXN ) -19% Intercept ( ICPT ) -25% Vertex ( VRTX ) -18% Regeneron ( REGN ) -11% Medivation ( MDVN ) -28% Pharmacyclics

    3. From Barron’s, March 31, 2014 (Part 2)

      Commentary

      Sat, 29 Mar 2014

      market performance relative to sectors such as IT that require lesser capex. Some highflyers sank last week, e.g. biotechs [ ALXN , CELG, GILD, REGN ] and other momentum favorites [ GMCR, FB, TWTR, P, YELP, NFLX, BIDU ]; fears of higher rates and

    4. Morgan Stanley has 44 stocks on its radar as takeover targets

      Headlines

      Mon, 24 Mar 2014

      TPX , EAT , BYI , DWA , JCP , AEO . Consumer staples: INGR , HAIN , HSH , WWAV . Health care: CELG , ESRX , WLP , REGN , ALXN , AET , CI , BDX , CERN . Financial: NSM . Tech: BRCD , ONNN , TIBX , SPWR , IM , JBL , SUNE , TER , ARRS , NSR . Telecom

    5. Time To Sell Alexion?

      Headlines

      Mon, 24 Mar 2014

      By ONeil Trader : Shares of Alexion ( ALXN ) have risen more than 80% from its late October 2013 lows, and although the stock is down 20% from its February high, I would

    6. New Morningstar Analyst Report for Alexion Pharmaceuticals , Inc.

      Stock Reports

      Tue, 11 Mar 2014

      Alexion should be able to leverage its existing infrastructure for the development and marketing of the drug. Alexion Pharmaceuticals specializes in the development and marketing of drugs for life-threatening medical conditions. The firm

    7. Celldex Therapeutics Is Shutting Down CDX-1135: What Does It Mean?

      Headlines

      Mon, 10 Mar 2014

      last year. It was being tested to treat a disease that affects just 300-500 patients in the U.S., and for this indication has very limited fundamental upside. Yet, it's similar to Alexion Pharmaceuticals 's ( ALXN ) Complete Story »

    8. Alexion ups guidance

      Headlines

      Mon, 10 Mar 2014

      Alexion Pharmaceuticals ( ALXN ) ups its 2014 EPS guidance to $4.37 to $4.47 from $3.70 - $3.80 citing improved reimbursement for Soliris in France

    9. Alexion to book additional Soliris sales, raises outlook

      Headlines

      Mon, 10 Mar 2014

      March 10 (Reuters) - Alexion Pharmaceuticals Inc revised its profit and sales outlook for the year after the French government agreed to raise reimbursement payments for the company's lead drug, Soliris.

    10. Questcor - Let's Compare Numbers

      Headlines

      Thu, 6 Mar 2014

      tracking along with QCOR for some time now. I also believe they make fine comparisons. The companies are: Alexion Pharmaceuticals ( ALXN ), Salix Pharmaceutical ( SLXP ), Jazz Pharmaceutical ( JAZZ ) Fortunately we have a good stretch of performance

    « Prev12345Next »
    Content Partners